Cardinal Health stock gains on solid analyst backing and steady price

Published on 09/10/2026 at 18:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock traded around USD 240 on September 10, 2026, with analysts seeing roughly 11 percent upside based on a consensus target. Recent results and guidance keep the healthcare distributor in moderate-buy territory for many houses.

Fotorealistisches Pharma-Distributionslager mit Gabelstapler und Mitarbeitern in Dublin Ohio — Cardinal Health Inc. betreibt ein modernes Pharma-Distributionslager in Dublin, Ohio – ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health stock (ISIN US14149Y1082) traded near USD 240 on September 10, 2026, leaving the healthcare distributor valued at about USD 56.0 billion and within reach of its 52-week high of USD 258.30, according to MarketBeat data as of that day.

Analyst consensus supports upside

According to MarketBeat on September 10, 2026, Cardinal Health carries a consensus rating of Moderate Buy, based on 16 buy and 3 hold recommendations and no sell ratings, with an average rating score of 2.84 on its scale.

The same overview from MarketBeat reports a consensus price target of USD 266.56 for Cardinal Health stock, implying approximately 11.1% upside from a reference level of USD 239.90 as of that snapshot, a quantified gap that many investors use as a guide to potential return.

Recent trading and valuation context

In intraday trading on September 10, 2026, Cardinal Health shares were cited opening at USD 240.31 on the New York Stock Exchange, according to a position update on the stock by MarketBeat, which highlighted institutional interest in the name.

The same MarketBeat stock page lists a 52-week trading range for Cardinal Health shares between USD 145.87 and USD 258.30, so a price around USD 240 as of September 10, 2026 sits roughly in the upper half of that range and about 7% below the 52-week high, while still clearly above the 52-week low by more than 60%.

Fundamental backdrop and earnings window

Cardinal Health, Inc. is described by MarketBeat as a healthcare services and products company supporting pharmaceutical and medical industries, and the same overview cites a price-to-earnings ratio of 33.27 and a dividend yield of 0.86% as of September 10, 2026, giving investors a sense of valuation and income profile.

While detailed quarterly revenue and earnings figures are not broken out in the week-filtered sources, Cardinal Health's current valuation multiples and dividend yield, as reported by MarketBeat, suggest investors are paying more than 33 times trailing earnings for exposure to its distribution and services footprint and receiving a cash yield just under 1% per year at recent prices.

Closing price perspective for investors

For investors tracking Cardinal Health stock, a reference price around USD 240 on the New York Stock Exchange as of September 10, 2026, with a market capitalization of approximately USD 56.0 billion and a 52-week range between USD 145.87 and USD 258.30, positions the shares as a large-cap healthcare distributor with moderate upside versus the consensus target and trading nearer to its yearly highs than its lows.